Immunotherapy drugs for lung cancer include nabulizumab and pembrolizumab, etc., which should be used according to doctor’s prescription. 1. Navulizumab: It is the first IgG4 monoclonal antibody, which can inhibit the proliferation of T-cells and the production of cytokines, release the inhibition of immune surveillance, and thus play the role of anti-tumor drugs. It has therapeutic effect on lung cancer patients. However, it is easy to cause back pain, skin blistering and other adverse reactions. It is forbidden for women during pregnancy. 2. Pabolizumab: it is a kind of PD-1 humanized monoclonal antibody, which binds with the ligands PD-L1 and PD-L2 of PD-1 receptor on T cells, inhibits the proliferation of T cells and the production of cytokines, and reduces the size of tumors, so as to achieve the effect of anti-tumor. It has certain therapeutic effects on patients with advanced lung cancer. Note that it is forbidden for patients who are allergic to this product. Common adverse reactions include nausea, vomiting and constipation. Besides this there are also the drugs of Duvarizumab and Atilizumab. The above drugs need to be used under the guidance of a doctor, do not use on your own to avoid delay.